Issue Date: March 28, 2016
C&EN profiles Amyris, biobased specialties maker
For biobased chemical firms, reaching commercial-scale production is a huge milestone and a trial by fire. Amyris, which was founded in 2003 as a lab-based start-up, is one of very few firms that have made it.
Starting in 2013, Amyris has ramped up output of specialty chemicals based on farnesene, a microbially produced terpene, in Brotas, Brazil, with partner Bunge. Farnesene, and molecules fashioned from it, is being used in both industrial applications and high-margin . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society